Dr. Coveler is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
825 Eastlake Ave E
Seattle, WA 98109Phone+1 206-606-6491Fax+1 206-606-2042
Summary
- I am a medical oncologist who treats cancers of the gastrointestinal system and also the director of the Pancreatic Cancer Specialty Clinic at Seattle Cancer Care Alliance. My goal is to be an educator for my patients and to guide them through the unknown and advocate for their choices when it comes to their care. I find this provides my patients with optimal care and permits them to create a plan that empowers them to confront the disease on their own terms. My clinical areas of expertise include gastrointestinal oncology, clinical immunotherapy, and early phase clinical trials.
Education & Training
- University of WashingtonFellowship, Hematology and Medical Oncology, 2007 - 2010
- Baylor College of MedicineInternship, Internal Medicine, 2002 - 2003
- Northwestern University The Feinberg School of MedicineClass of 2002
- Northwestern UniversityBachelor of Arts, Biology, Magna Cum Laude, 1995 - 1998
Certifications & Licensure
- FL State Medical License 2021 - Present
- WA State Medical License 2005 - 2026
- ID State Medical License 2022 - 2025
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Perioperative Therapy for Resectable Pancreatic Cancer Start of enrollment: 2008 Jan 01
- Immunotherapy Study in Borderline Resectable or Locally Advanced Unresectable Pancreatic Cancer Start of enrollment: 2013 May 01
Publications & Presentations
PubMed
- 74 citationsPhase I/II study of the hypoxia-activated prodrug PR104 in refractory/relapsed acute myeloid leukemia and acute lymphoblastic leukemia.Marina Konopleva, Peter F. Thall, Cecilia Arana Yi, Gautam Borthakur, Andrew Coveler
Haematologica. 2015-07-01 - 28 citationsPancreatic cancer: Update on immunotherapies and algenpantucel-LKinsey A. McCormick, Andrew L. Coveler, Gabriela R. Rossi, Nicholas N. Vahanian, Charles J. Link
Human Vaccines & Immunotherapeutics. 2016-03-03 - 212 citationsConcurrent Trastuzumab and HER2/neu-Specific Vaccination in Patients With Metastatic Breast CancerMary L. Disis, Danelle R. Wallace, Ted Gooley, Yushe Dang, Meredith Slota
Journal of Clinical Oncology. 2009-10-01
Journal Articles
- KRASG12C Inhibition with Sotorasib in Advanced Solid TumorsDavid S Hong, Marwan G Fakih, Gregory A Durm, Geoffrey I Shapiro, Gerald S Falchook, Adrian Sacher, Crystal S Denlinger, John C Krauss, Andrew L Coveler, Suresh S Rama..., The New England Journal of Medicine
Press Mentions
- Fred Hutch at ASCO: New Insights on Financial Toxicity, Combination Therapies for Cancer and the Need for Targeted Breast Cancer Therapies in UgandaMay 26th, 2023
- NuCana Presents Favorable Data on NUC-3373 at the European Society of Medical Oncology (ESMO) Annual Meeting 2022September 12th, 2022
- Fred Hutch Experts Highlight Research on Cancer Treatment Advances, Survivorship and Precision Oncology at ASCOJune 6th, 2023
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: